Critical Illness Insurance Market Report 2026

The critical illness insurance market size has grown marginally in recent years. It will grow from $330.36 billion in 2025 to $330.36 billion in 2026 at a compound annual growth rate (CAGR) of 0%. The growth in the historic period can be attributed to rising prevalence of lifestyle-related diseases, increasing awareness of financial health protection, expansion of private health insurance coverage, growing urban population with higher insurance adoption, improvements in medical diagnostics.

The critical illness insurance market size is expected to see rapid growth in the next few years. It will grow to $621.43 billion in 2030 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing demand for comprehensive health coverage, rising integration of ai in underwriting, expansion of digital health ecosystems, growing focus on preventive healthcare coverage, increasing penetration in emerging economies. Major trends in the forecast period include increasing adoption of customizable critical illness policies, rising use of digital policy distribution channels, growing integration of health data analytics, expansion of riders and add-on coverage options, enhanced focus on faster claim settlement.

The rising prevalence of critical illnesses is fueling the growth of the global critical illness insurance market. Treatments for serious conditions, such as cancer, often involve significant expenses, making critical illness insurance an important tool to reduce the financial burden. Insurance providers offer a lump-sum payment to policyholders upon the diagnosis of a covered critical illness. Common critical illnesses include heart attack, stroke, and coronary artery bypass surgery. For example, in July 2024, according to the Australian Institute of Health and Welfare, a government agency in Australia, approximately 165,000 new cancer cases were diagnosed in 2023, averaging over 450 diagnoses per day. Consequently, the increasing prevalence of critical illnesses is driving demand for critical illness insurance.

Rising healthcare expenditure is also expected to support the expansion of the critical illness insurance market. Healthcare expenditure refers to the total spending on medical goods and services within a healthcare system or economy and plays a vital role in enabling access to and development of critical illness insurance. For instance, in April 2025, the American Medical Association, a U.S.-based professional association, reported that U.S. health spending increased by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per person, up from a 4.6% increase in 2022. Therefore, the growth in healthcare spending is contributing to the market expansion of critical illness insurance.

Companies in the critical illness insurance market are increasingly developing innovative products to cater to a growing customer base and enhance revenue. Critical illness insurance, also known as critical illness cover or dread disease policies, provides financial protection to individuals diagnosed with serious illnesses. For example, in October 2023, Huize Holding Limited partnered with Junlong Life to launch the Guardian Critical Care No.6 policy. This policy offers coverage for over 120 severe illnesses, supports up to 18 claims for mild-to-severe illnesses, imposes no restrictions on multiple claims arising from the same cause, treatment, or accident, and provides ICU hospitalization benefits of 30% of the sum assured for stays of seven or more consecutive days. This approach reflects the ongoing innovation in critical illness insurance products to meet growing consumer needs.

Major companies operating in the critical illness insurance market are China Life Insurance Company Limited, Allianz SE, Ping An Insurance Company of China Ltd., Aviva plc, Legal and General Group plc, China Pacific Insurance Co. Ltd., Prudential plc, New China Life Insurance Co. Ltd., Aegon NV, AXA SA, American International Group Inc., Sun Life Financial Inc., Aflac Inc., Huaxia Life Insurance Co., Ltd., MetLife Inc., Zurich Insurance Group Ltd., Hospitals Contribution Fund of Australia Limited, Dai-ichi Life Insurance Company Limited, UnitedHealthcare Inc., Liberty Mutual Group, Bajaj Allianz General Insurance Company Limited, Cigna Group, Future Generali India Insurance Company Limited, Royal London Mutual Insurance Society Limited, Plum Benefits Private Limited, Tata AIG General Insurance Company Limited, AmMetLife Insurance Berhad, Manulife Financial Corporation, Great-West Lifeco Inc., Canada Life Assurance Company, Chubb Limited, Assurity Life Insurance Company, Colonial Life and Accident Insurance Company, Mutual of Omaha, New York Life Insurance Company.

North America was the largest region in the critical illness insurance market in 2025. Asia-Pacific was the second largest region in the critical illness insurance market report. The regions covered in the critical illness insurance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the critical illness insurance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The critical illness insurance market consists of sales of critical illness insurance products by entities that are engaged in directly underwriting critical illness cover or a dread disease policy, which is an additional insurance coverage to cover those overruns where traditional health insurance may fall short. The insurance industry is categorized on the basis of the business model of the firms present in the industry. Some insurance firms may offer other services financial or otherwise. Contributions and premiums are set on the basis of actuarial calculations of probable payouts based on risk factors from experience tables and expected investment returns on reserves. The value of the market is based on the premiums paid by the insured. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.